Storage requires refrigeration at 2 to 8 degrees Celsius, consistent with standard peptide storage guidelines
Since visceral fat (fat around the abdomen) is closely linked to metabolic health issues, reducing it can significantly improve conditions like insulin resistance, high cholesterol, and cardiovascular risk
These cardiovascular effects suggest potential applications in ischemic heart disease, peripheral vascular disease, and vascular injury, though clinical translation requires confirmation of effects in human subjects
Most people describe a gradual shift over several weeks
Oral GHK-Cu dosing research considers bioavailability differently than injectable research, because oral administration involves gastrointestinal processing before systemic distribution
Yes, we accept payment from FSA/HSA accounts